CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Lung cancer screening with low-dose chest computed tomography (CT) is currently recommended for high-risk individuals who are 50 to...
Seattle, Washington, United States and 6 other locations
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
Seattle, Washington, United States and 18 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Seattle, Washington, United States and 72 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Tacoma, Washington, United States and 210 other locations
to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...
Phase 3
Renton, Washington, United States and 50 other locations
The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.
Phase 1
Seattle, Washington, United States and 31 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Seattle, Washington, United States and 124 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Seattle, Washington, United States and 263 other locations
This study was designed to evaluate safety and antitumor activity of HER3-DXd in two parts: Dose Escalation and Dose Expansion.In Dose Escalation, HE...
Phase 1
Seattle, Washington, United States and 36 other locations
The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The aims of this study are to see how safe an...
Phase 2
Tacoma, Washington, United States and 52 other locations
Clinical trials
Research sites
Resources
Legal